34 results on '"Tamminen, Kirsi"'
Search Results
2. Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform
3. Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens
4. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes
5. A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
6. Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays
7. Safety and immunogenicity studies in animal models support clinical development of a bivalent norovirus-like particle vaccine produced in plants
8. Assessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice
9. Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology
10. Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses
11. Internalization and antigen presentation by mouse dendritic cells of rotavirus VP6 preparations differing in nanostructure
12. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles
13. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles
14. Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform
15. Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only
16. Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo
17. Early life exposure to common virus infections did not differ between coeliac disease patients and controls
18. Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana
19. Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant
20. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera
21. Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigens
22. Norovirus-Specific Memory T Cell Responses in Adult Human Donors
23. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein
24. Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding
25. Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles
26. Genotype Considerations for Virus-Like Particle-Based Bivalent Norovirus Vaccine Composition
27. Assessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice.
28. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo
29. The gross motor skills in children with communication disorders before and after the training program
30. Trivalent Combination Vaccine Induces Broad Heterologous Immune Responses to Norovirus and Rotavirus in Mice
31. Pre-existing Immunity to Norovirus GII-4 Virus-Like Particles Does Not Impairde NovoImmune Responses to Norovirus GII-12 Genotype
32. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles
33. Early-life exposure to common virus infections did not differ between coeliac disease patients and controls.
34. Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.